Record title

PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study

Record identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eddd24c943b4457a9f6b80de4dde2c34

https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eddd24c943b4457a9f6b80de4dde2c34

PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study

About this item

Full title

PCSK9 inhibitor recaticimab for hypercholesterolemia on stable statin dose: a randomized, double-blind, placebo-controlled phase 1b/2 study

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2022, Vol.20 (1), p.13-13

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eddd24c943b4457a9f6b80de4dde2c34

Language

English

Formats

Publication information

Publisher

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_eddd24c943b4457a9f6b80de4dde2c34

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_eddd24c943b4457a9f6b80de4dde2c34

Other Identifiers

ISSN

E-ISSN

DOI

How to access this item